Please try another search
For the nine months ended 28 February 2022, Muromachi Chemicals Inc revenues increased 11% to Y4.09B. Net income increased from Y118.2M to Y299.7M. Revenues reflect Chemicals segment increase of 19% to Y1.44B, Health Food segment increase of 17% to Y667.8M, Pharmaceutical segment increase of 4% to Y1.97B. Net income benefited from Health Food segment income totaling Y21.9M vs. loss of Y52.4M, Chemicals segment loss decrease of 91% to Y2.5M.
Period Ending: | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 |
---|---|---|---|---|
Total Revenue | 1279.8 | 1479.7 | 1328.24 | 1255.69 |
Gross Profit | 345.07 | 469.44 | 485.63 | 392.87 |
Operating Income | 31.09 | 153.92 | 169.33 | 41.2 |
Net Income | 37.83 | 139.59 | 122.31 | 62.55 |
Period Ending: | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 |
---|---|---|---|---|
Total Assets | 4553.48 | 4529.06 | 4528.88 | 4612.32 |
Total Liabilities | 2952.8 | 2963.78 | 3125.43 | 3278.32 |
Total Equity | 1600.68 | 1565.29 | 1403.45 | 1334 |
Period Ending: | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 12 Months |
Cash From Operating Activities | 151.69 | 487.67 | ||
Cash From Investing Activities | -56.36 | -57.73 | ||
Cash From Financing Activities | -257.05 | -310.51 | ||
Net Change in Cash | -161.72 | 119.42 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review